6.27.2018

Morbius: Jared Leto Officially Cast as The Living Vampire

     In an out-of-left-field announcement, Sony has announced that Jared Leto has been cast in a Morbius film, based on the 1971 comic character created by Gil Kane and Roy Thomas for Amazing Spider-Man 101.
     This comes as an odd surprise as Morbius has never been a huge character in the Spider-Man universe, whereas the Venom film makes sense because he's been in countless issues and series as well as being wildly popular as a dark and gritty anti-hero.  Morbius has only appeared periodically since that first issue and even had a solo-series for a few years.

     Michael Morbius was a scientist with a rare blood disorder, and in a typical old horror story fashion through an effort to cure the disease via a science experiment gone wrong, he instead transformed himself into a pseudo-vampire- along with all the vampire-like traits that come with it such as enhanced strength, speed, a healing factor, night vision, echolocation, and the classic vampire staple- a thirst for blood.

     He began as a foe of the friendly neighborhood Spider-Man, and eventually grew to be a tragic anti-hero and fight for the side of good.  Perhaps Leto will be able to really nail the tragic dichotomy of a man torn between seeking to do good and fighting his inhuman lust for blood.  Rumors say that Daniel Espinoza (Safe House) is going to be directing the feature, so hopefully we'll get something more character accurate than Leto's bizarre take on the Joker from Suicide Squad.  In addition, Matt Sazama and Burk Sharpless are writing the script, and they will be overseen by Palak Patel.
     Now I'm curious to know if Sony hold the cinematic rights to Jack Russel, of Marvel Comics' Werewolf By Night. Or if they'll have a cameo appearance of either Venom or Spider-Man considering the relation of the properties.

     Morbius has no set release window yet.

     Venom is set to release October 5th.

     Spider-Man: Far From Home is slated for early July 2019 release.

     Source [ Variety ]

No comments:

Post a Comment